A Single Center, Single Arm Clinical Study on the Treatment of Advanced Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations and Failed EGFR TKIs With the Combination of Enrotinib and Paclitaxel Monoclonal Antibody
Conditions: Lung Cancer; TKI Resistance; EGFR Sensitive Mutation; Anlotinib; Pianzumab Interventions: Drug: Anlotinib; Drug: Penpulimab Sponsors: Degan Lu; Wu Jieping Medical Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials